Regulation

Filter

Current filters:

None

Popular Filters

2576 to 2600 of 2715 results

US FDA delays Eliquis decision; Pristiq dropped for menopause

02-03-2012

USA drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) say that the US Food and…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalPristiqRegulationWomen's Health

Biogen Idec files oral MS candidate in USA

01-03-2012

US biotech firm Biogen Idec (Nadaq: BIIB) has submitted its orally-active drug for relapsing-remitting…

Biogen IdecBiotechnologyNeurologicalRegulation

EMA increases public information on conflicts of interest of experts and management

01-03-2012

The European Medicines Agency this week updated its list of European experts to display each expert's…

EuropeManagementPharmaceuticalRegulation

Hi-Tech and Mylan update on generics

01-03-2012

US generic drugmaker Hi-Tech Pharmacal (Nasdaq: HITK) says that the US Food and Drug Administration has…

GenericsMarkets & MarketingNeurologicalNorth AmericaRegulation

FDA OKs first quadrivalent flu vaccine; and lower dose Angeliq

01-03-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) US unit MedImmune's FluMist Quadrivalent, a vaccine to…

Anti-viralsNorth AmericaPharmaceuticalRegulationVaccinesWomen's Health

FDA expands on cholesterol-lowering drug risks

29-02-2012

Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins…

AstraZenecaCardio-vascularCrestorLipitorMerck & CoNorth AmericaPfizerPharmaceuticalRegulationZocor

Bayer and J&J’s Xarelto gets US Priority Review for new indication

29-02-2012

The US Food and Drug Administration has granted Priority Review designation to the supplemental New Drug…

BayerCardio-vascularJanssenJohnson & JohnsonNorth AmericaPharmaceuticalRegulationXarelto

Frontage and Fanghui Pharma launch $10 million collaboration

28-02-2012

Emerging Chinese pharmaceutical company Luohe Fanghui Pharmaceutical has launched a new globalization…

Asia-PacificFanghui PharmaceuticalsFinancialFrontage LaboratoriesGenericsNorth AmericaRegulation

Merck warned for not carrying out post-approval sitagliptin study

28-02-2012

The US Food and Drug Administration (FDA) has sent a warning letter to Merck & Co for failing to carry…

DiabetesJanumetJanuviaMerck & CoPharmaceuticalRegulationsitagliptinSitagliptin Metformin HCL

GSK boss accuses UK government of blocking new drugs to save money

27-02-2012

The chief executive of the UK’s largest pharmaceutical company, GlaxoSmithKline (LSE: GSK) has accused…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalPricingRegulation

No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG

27-02-2012

In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…

EuropeGlaxoSmithKlineNeurologicalPharmaceuticalPricingRegulationTrobalt

Forest Labs get EU appro for Colobreathe

27-02-2012

US drugmaker Forest Laboratories (NYSE: FRX) said on Friday that the European Medicines Agency has approved…

ColoBreatheColomycinEuropeForest LaboratoriesPharmaceuticalRare diseasesRegulation

Access Pharma’s MuGard OKed in China

26-02-2012

USA-based specialist in supportive care for cancer patients Access Pharmaceuticals (OTCBB: ACCP) revealed…

Access PharmaceuticalsAsia-PacificJain An PharmaceuticalsMuGardOncologyPharmaceuticalRegulationRhei Pharmaceuticals

Quintiles to expand clinical development capabilities in Russia

26-02-2012

Biopharmaceutical services company Quintiles is moving further into emerging markets, last week signing…

EuropePharmaceuticalQuintilesRegulationResearchRVC Biofund

GTx stock takes a pounding as FDA puts clinical hold on Capesaris trial

24-02-2012

Tennessee, USA-based GTx (Nasdaq: GTXI) saw its shares plunge 30% to $3.98 earlier this week, after…

CapesarisFinancialGTxNorth AmericaOncologyPharmaceuticalRegulationResearch

Mylan gets tentative FDA approval for generic Epzicom

23-02-2012

US generics major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Laboratories has received tentative…

Anti-viralsEpzicomGenericsGlaxoSmithKlineMylan LaboratoriesNorth AmericaPfizerRegulationViiV Healthcare

FDA advisory panel backs approval of Qnexa

23-02-2012

At last there was finally some good news for drug developer Vivus (Nasdaq: VVUS) - and Americans with…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

EMA approves Shire Vpriv plant in USA

23-02-2012

Ireland-headquartered biopharma firm Shire (LSE: SHP) says that the European Medicines Agency's Committee…

BiotechnologyFinancialNorth AmericaPharmaceuticalRare diseasesRegulationReplagalShireVpriv

Additional indications in Japan for Diagnogreen and Sawacillin

22-02-2012

Japanese drug major Daiichi Sankyo (TYO: 4568) says it has received approval in Japan for a supplemental…

Antibiotics and Infectious diseasesAsia-PacificAstellas PharmaDaiichi SankyoPharmaceuticalRegulationSawacillin

Nine news Rx drugs added to Australian PBS listings

22-02-2012

Australia’s Federal Minister for Health, Tanya Plibersek, yesterday announced the listing of nine…

Asia-PacificAstraZenecaBrilintaGlaxoSmithKlinePharmaceuticalPricingRegulationZinnat

NICE backs Roche RoActemra, but with PAS discount

22-02-2012

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today recommended…

Anti-Arthritics/RheumaticsEuropePharmaceuticalPricingRegulationRoActemraRoche

2576 to 2600 of 2715 results

Back to top